Skip to main content

Table 3 Factors which influenced patients’ decision to participate in a clinical trial

From: Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey

Reason

CTIMP

Pre-screening

Non-CTIMP

All

N (%)

N (%)

N (%)

(n = 241)

(n = 63)

(n = 28)

(n = 150)

Patient felt the trial offered the best available treatment

49 (78 %)

16 (57 %)

57 (39 %)

122 (51 %)

Patient felt the trial result could benefit others

53 (84 %)

24 (86 %)

143 (96 %)

220 (92 %)

Patient wanted to contribute to scientific research

37 (59 %)

16 (57 %)

111 (74 %)

164 (68 %)

Patient felt they would be monitored more closely

28 (44 %)

9 (32 %)

42 (28 %)

79 (33 %)

Patient felt they would have better quality care

20 (32 %)

5 (18 %)

24 (16 %)

49 (20 %)

Patient’s family were keen for patient to participate

24 (38 %)

8 (29 %)

20 (13 %)

52 (22 %)

Patient trusted the doctor treating them

38 (60 %)

10 (36 %)

73 (49 %)

121 (50 %)

Patient felt that otherwise their cancer will get worse

17 (27 %)

3 (11 %)

13 (9 %)

33 (14 %)

Other reason

4 (6 %)

0 (0 %)

8 (5 %)

12 (5 %)

  1. Key: CTIMP = Clinical Trial of an Investigational Medicinal Product, pre-screening = molecular pre-screening to determine potential eligibility for a specific CTIMP study